Thermo Fisher Scientific (TMO)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 9 |
Ownership rank: | 31 |
% of all portfolios: | 0.253% |
Hold Price * : | $581.21 |
History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
Q3  2011 | |||||
≡ | Steven Romick - FPA Crescent Fund | Add 205.38% | 1,068,000 | 1.40 | |
≡ | Robert Olstein - Olstein Capital Management | Add 29.59% | 29,000 | 0.31 | |
Q1  2011 | |||||
≡ | Steven Romick - FPA Crescent Fund | Buy | 520,000 | 0.88 | |
Q3  2010 | |||||
≡ | Robert Olstein - Olstein Capital Management | Add 13.79% | 20,000 | 0.17 | |
Q1  2010 | |||||
≡ | John Rogers - Ariel Appreciation Fund | Add 10.91% | 83,800 | 0.28 | |
Q4  2009 | |||||
≡ | John Rogers - Ariel Appreciation Fund | Add 10.57% | 73,400 | 0.25 | |
Q2  2009 | |||||
≡ | John Rogers - Ariel Appreciation Fund | Add 18.29% | 118,600 | 0.51 | |
≡ | Dodge & Cox | Buy | 614,115 | 0.08 | |
≡ | Robert Olstein - Olstein Capital Management | Add 2.50% | 4,700 | 0.04 | |
Q1  2009 | |||||
≡ | Robert Olstein - Olstein Capital Management | Add 38.73% | 52,400 | 0.42 | |
Q4  2008 | |||||
≡ | Robert Olstein - Olstein Capital Management | Buy | 135,300 | 0.88 | |
Q2  2007 | |||||
≡ | Dodge & Cox | Add 0.01% | 1,000 | 0.00 | |
Q1  2007 | |||||
≡ | Dodge & Cox | Add 0.03% | 2,400 | 0.00 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.